vs
COMMVAULT SYSTEMS INC（CVLT）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是COMMVAULT SYSTEMS INC的2.0倍（$622.0M vs $311.7M），Royalty Pharma plc净利率更高（34.4% vs 4.7%，领先29.7%），COMMVAULT SYSTEMS INC同比增速更快（13.3% vs 4.8%），过去两年COMMVAULT SYSTEMS INC的营收复合增速更高（17.8% vs 4.6%）
Commvault Systems Inc.是美国上市的网络安全与数据保护软件企业，核心业务覆盖数据安全、云服务及基础设施管理领域，旗下方案广泛应用于各类企业的数据资产防护与IT架构运维场景，助力客户降低数据风险、提升云环境运营效率。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CVLT vs RPRX — 直观对比
营收规模更大
RPRX
是对方的2.0倍
$311.7M
营收增速更快
CVLT
高出8.6%
4.8%
净利率更高
RPRX
高出29.7%
4.7%
两年增速更快
CVLT
近两年复合增速
4.6%
损益表 — Q4 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $311.7M | $622.0M |
| 净利润 | $14.6M | $214.2M |
| 毛利率 | 81.4% | — |
| 营业利润率 | 5.3% | 62.4% |
| 净利率 | 4.7% | 34.4% |
| 营收同比 | 13.3% | 4.8% |
| 净利润同比 | — | 2.9% |
| 每股收益（稀释后） | $0.34 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CVLTRPRX
| Q1 26 | $311.7M | — | ||
| Q4 25 | $313.8M | $622.0M | ||
| Q3 25 | $276.2M | $609.3M | ||
| Q2 25 | $282.0M | $578.7M | ||
| Q1 25 | $275.0M | $568.2M | ||
| Q4 24 | $262.6M | $593.6M | ||
| Q3 24 | $233.3M | $564.7M | ||
| Q2 24 | $224.7M | $537.3M |
净利润CVLTRPRX
| Q1 26 | $14.6M | — | ||
| Q4 25 | $17.8M | $214.2M | ||
| Q3 25 | $14.7M | $288.2M | ||
| Q2 25 | $23.5M | $30.2M | ||
| Q1 25 | $31.0M | $238.3M | ||
| Q4 24 | $11.0M | $208.2M | ||
| Q3 24 | $15.6M | $544.0M | ||
| Q2 24 | $18.5M | $102.0M |
毛利率CVLTRPRX
| Q1 26 | 81.4% | — | ||
| Q4 25 | 81.1% | — | ||
| Q3 25 | 80.1% | — | ||
| Q2 25 | 82.0% | — | ||
| Q1 25 | 82.6% | — | ||
| Q4 24 | 81.5% | — | ||
| Q3 24 | 81.6% | — | ||
| Q2 24 | 82.3% | — |
营业利润率CVLTRPRX
| Q1 26 | 5.3% | — | ||
| Q4 25 | 6.3% | 62.4% | ||
| Q3 25 | 4.5% | 70.1% | ||
| Q2 25 | 8.9% | 36.3% | ||
| Q1 25 | 9.7% | 94.0% | ||
| Q4 24 | 5.2% | 60.9% | ||
| Q3 24 | 6.4% | — | ||
| Q2 24 | 8.2% | 50.2% |
净利率CVLTRPRX
| Q1 26 | 4.7% | — | ||
| Q4 25 | 5.7% | 34.4% | ||
| Q3 25 | 5.3% | 47.3% | ||
| Q2 25 | 8.3% | 5.2% | ||
| Q1 25 | 11.3% | 41.9% | ||
| Q4 24 | 4.2% | 35.1% | ||
| Q3 24 | 6.7% | 96.3% | ||
| Q2 24 | 8.2% | 19.0% |
每股收益（稀释后）CVLTRPRX
| Q1 26 | $0.34 | — | ||
| Q4 25 | $0.40 | $0.49 | ||
| Q3 25 | $0.33 | $0.67 | ||
| Q2 25 | $0.52 | $0.07 | ||
| Q1 25 | $0.68 | $0.55 | ||
| Q4 24 | $0.24 | $0.46 | ||
| Q3 24 | $0.35 | $1.21 | ||
| Q2 24 | $0.41 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $900.0M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $7.5M | $9.7B |
| 总资产 | $1.9B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CVLTRPRX
| Q1 26 | $900.0M | — | ||
| Q4 25 | $1.0B | $618.7M | ||
| Q3 25 | $1.1B | $938.9M | ||
| Q2 25 | $363.2M | $631.9M | ||
| Q1 25 | $302.1M | $1.1B | ||
| Q4 24 | $243.6M | $929.0M | ||
| Q3 24 | $303.1M | $950.1M | ||
| Q2 24 | $287.9M | $1.8B |
总债务CVLTRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B |
股东权益CVLTRPRX
| Q1 26 | $7.5M | — | ||
| Q4 25 | $216.7M | $9.7B | ||
| Q3 25 | $210.5M | $9.6B | ||
| Q2 25 | $364.7M | $9.5B | ||
| Q1 25 | $325.1M | $9.8B | ||
| Q4 24 | $287.8M | $10.3B | ||
| Q3 24 | $277.8M | $10.3B | ||
| Q2 24 | $281.8M | $9.8B |
总资产CVLTRPRX
| Q1 26 | $1.9B | — | ||
| Q4 25 | $2.0B | $19.6B | ||
| Q3 25 | $1.9B | $19.3B | ||
| Q2 25 | $1.2B | $18.3B | ||
| Q1 25 | $1.1B | $17.6B | ||
| Q4 24 | $1.0B | $18.2B | ||
| Q3 24 | $958.5M | $18.0B | ||
| Q2 24 | $934.9M | $17.7B |
负债/权益比CVLTRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $132.2M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $131.8M | — |
| 自由现金流率自由现金流/营收 | 42.3% | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 9.02× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $237.2M | — |
8季度趋势，按日历期对齐
经营现金流CVLTRPRX
| Q1 26 | $132.2M | — | ||
| Q4 25 | $4.0M | $827.1M | ||
| Q3 25 | $76.8M | $702.6M | ||
| Q2 25 | $31.7M | $364.0M | ||
| Q1 25 | $77.0M | $596.1M | ||
| Q4 24 | $30.1M | $742.5M | ||
| Q3 24 | $55.6M | $703.6M | ||
| Q2 24 | $44.7M | $658.2M |
自由现金流CVLTRPRX
| Q1 26 | $131.8M | — | ||
| Q4 25 | $1.9M | — | ||
| Q3 25 | $73.6M | — | ||
| Q2 25 | $29.8M | — | ||
| Q1 25 | $76.2M | — | ||
| Q4 24 | $29.9M | — | ||
| Q3 24 | $53.7M | — | ||
| Q2 24 | $43.8M | — |
自由现金流率CVLTRPRX
| Q1 26 | 42.3% | — | ||
| Q4 25 | 0.6% | — | ||
| Q3 25 | 26.6% | — | ||
| Q2 25 | 10.6% | — | ||
| Q1 25 | 27.7% | — | ||
| Q4 24 | 11.4% | — | ||
| Q3 24 | 23.0% | — | ||
| Q2 24 | 19.5% | — |
资本支出强度CVLTRPRX
| Q1 26 | — | — | ||
| Q4 25 | 0.7% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 0.4% | — |
现金转化率CVLTRPRX
| Q1 26 | 9.02× | — | ||
| Q4 25 | 0.23× | 3.86× | ||
| Q3 25 | 5.21× | 2.44× | ||
| Q2 25 | 1.35× | 12.06× | ||
| Q1 25 | 2.48× | 2.50× | ||
| Q4 24 | 2.74× | 3.57× | ||
| Q3 24 | 3.57× | 1.29× | ||
| Q2 24 | 2.41× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CVLT
| Term-based license | $114.4M | 37% |
| Software-as-a-service | $93.1M | 30% |
| Customer support | $80.9M | 26% |
| Other | $13.1M | 4% |
| Perpetual license | $10.1M | 3% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
